Jon Reed is a senior editor overseeing coverage for CNET's home, energy and utilities category. Jon has over a decade of experience of writing and reporting as a statehouse reporter in Columbus ...

There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline ...